R&D From reactive to predictive: How data is redefining pharma l... Pharmaceutical supply chains have more data at their fingertips than ever before. The challenge is turning that information into foresight.
R&D Hospital financial pressure is reshaping how we think about ... Health systems face the pressure of maintaining continuity of care in an environment where supply disruptions and drug shortages persist as concerns.
R&D Why storage resilience will protect the future of CAR-T Cell and gene therapies are changing the way pharmaceutical organisations think about sample storage.
R&D How medical supply chains are adapting to global disruptions From the lingering impacts of pandemic-era bottlenecks to geopolitical tensions and extreme weather events, medical supply chains are under pressure.
News UK firm steps in to ease medicine supply crisis in NHS Amid reports that a shortage of bone cement in the UK is leading to delayed orthopaedic surgeries, Biocomposites has brought forward a product launch.
Market Access Why the NHS needs to maximise the impact of biosimilars Ensuring the long-term sustainability of the NHS increasingly appears to be an unfathomable prospect.
News Lilly partners with Hims & Hers on obesity drug sales Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the telehealth company's platform.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.